isoliquiritigenin

Isoliquiritigenin is a lipid of Polyketides (PK) class. Isoliquiritigenin is associated with abnormalities such as abnormal fragmented structure, Gastric ulcer, Gastric mucosa lesion, Peptic Ulcer and Wiskott-Aldrich Syndrome. The involved functions are known as Mass-to-Charge Ratio, Anabolism, Oxidation, inhibitors and Energy Absorption. Isoliquiritigenin often locates in Microsomes, Liver, Hepatic, Microsomes, Immune system and Vacuole. The associated genes with Isoliquiritigenin are P4HTM gene, BCL2 gene, AP1AR gene, oxytocin, 1-desamino-(O-Et-Tyr)(2)- and ODAM gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of isoliquiritigenin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with isoliquiritigenin?

isoliquiritigenin is suspected in Gastric mucosa lesion, Gastric ulcer, Peptic Ulcer, Nodule, Infertility and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with isoliquiritigenin

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Precancerous Conditions D011230 48 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Leiomyoma D007889 8 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with isoliquiritigenin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with isoliquiritigenin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with isoliquiritigenin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with isoliquiritigenin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with isoliquiritigenin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with isoliquiritigenin?

Knock-out

Knock-out are used in the study 'Two activators of in vitro fertilization in mice from licorice.' (Tung NH et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with isoliquiritigenin

Download all related citations
Per page 10 20 50 100 | Total 275
Authors Title Published Journal PubMed Link
Srinivasan B et al. Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies. 2011 Bioorg. Med. Chem. Lett. pmid:21112783
Iwashita K et al. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. 2000 Biosci. Biotechnol. Biochem. pmid:11055382
Hwang CK and Chun HS Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons. 2012 Biosci. Biotechnol. Biochem. pmid:22451397
Chen T et al. The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell. 2017 BMC Pharmacol Toxicol pmid:28716056
Jhanji V et al. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models. 2011 Br J Ophthalmol pmid:21719569
Yu SM and Kuo SC Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. 1995 Br. J. Pharmacol. pmid:7599926
Yamazaki S et al. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. 2002 Cancer Lett. pmid:12049811
Park I et al. Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition. 2009 Cancer Lett. pmid:19167809
Takahashi T et al. Cyclooxygenase-2 plays a suppressive role for induction of apoptosis in isoliquiritigenin-treated mouse colon cancer cells. 2006 Cancer Lett. pmid:16399234
Ii T et al. Induction of cell cycle arrest and p21(CIP1/WAF1) expression in human lung cancer cells by isoliquiritigenin. 2004 Cancer Lett. pmid:15050731
Cuendet M et al. Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice. 2010 Cancer Prev Res (Phila) pmid:20068129
Takahashi T et al. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. 2004 Cancer Sci. pmid:15132774
Kong BJ et al. Properties and in vitro drug release of hyaluronic acid-hydroxyethyl cellulose hydrogels for transdermal delivery of isoliquiritigenin. 2016 Carbohydr Polym pmid:27178954
Yamamoto S et al. The potent anti-tumor-promoting agent isoliquiritigenin. 1991 Carcinogenesis pmid:1899810
Wang N et al. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling. 2014 Carcinogenesis pmid:25194164
Sun C et al. Isoliquiritigenin enhances radiosensitivity of HepG2 cells via disturbance of redox status. 2013 Cell Biochem. Biophys. pmid:23086355
Chen H et al. Isoliquiritigenin-induced effects on Nrf2 mediated antioxidant defence in the HL-60 cell monocytic differentiation. 2013 Cell Biol. Int. pmid:23881796
Kong LD et al. Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. 2000 Cell. Mol. Life Sci. pmid:10823249
Kawakami Z et al. Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan. 2011 Cell. Mol. Neurobiol. pmid:21691759
Wu S et al. Isoliquiritigenin Inhibits Interferon-γ-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt Signaling Pathways. 2015 Cell. Physiol. Biochem. pmid:26315837
Lian D et al. Cathepsin B-Mediated NLRP3 Inflammasome Formation and Activation in Angiotensin II -Induced Hypertensive Mice: Role of Macrophage Digestion Dysfunction. 2018 Cell. Physiol. Biochem. pmid:30359991
Zhao Z et al. Isoliquiritigenin attenuates oxidative hepatic damage induced by carbon tetrachloride with or without buthionine sulfoximine. 2015 Chem. Biol. Interact. pmid:25450236
Wong TY et al. The licorice flavonoid isoliquiritigenin reduces DNA-binding activity of AhR in MCF-7 cells. 2014 Chem. Biol. Interact. pmid:25110319
Martin HJ et al. The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. 2003 Chem. Biol. Interact. pmid:14642735
Sano S et al. Reinvestigation of the synthesis of isoliquiritigenin: application of Horner-Wadsworth-Emmons reaction and Claisen-Schmidt condensation. 2011 Chem. Pharm. Bull. pmid:21720042
Hong H et al. Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities. 2012 Chem. Res. Toxicol. pmid:23013281
Hajirahimkhan A et al. Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A. 2015 Chem. Res. Toxicol. pmid:26473469
Dunlap TL et al. Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It. 2015 Chem. Res. Toxicol. pmid:26134484
Chen J et al. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway. 2018 Chemotherapy pmid:29936511
Hattori T et al. Saireito probably prevents mesangial cell proliferation in HIGA mice via PDGF-BB tyrosine kinase inhibition. 2007 Clin. Exp. Nephrol. pmid:18085387
Hsu YL et al. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells. 2004 Clin. Exp. Pharmacol. Physiol. pmid:15236626
Zhang X et al. Isoliquiritigenin, a natural anti-oxidant, selectively inhibits the proliferation of prostate cancer cells. 2010 Clin. Exp. Pharmacol. Physiol. pmid:20456427
Guo J et al. In vitro metabolism of isoliquiritigenin by human liver microsomes. 2008 Drug Metab. Dispos. pmid:18006650
Guo J et al. Biotransformation of the chemopreventive agent 2',4',4-trihydroxychalcone (isoliquiritigenin) by UDP-glucuronosyltransferases. 2008 Drug Metab. Dispos. pmid:18653743
Sung MW and Li PC Chemical analysis of raw, dry-roasted, and honey-roasted licorice by capillary electrophoresis. 2004 Electrophoresis pmid:15490450
Liu MM et al. Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy. 2012 Eur J Med Chem pmid:22445328
Chen YP et al. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase. 2013 Eur J Med Chem pmid:23786711
Park SM et al. Isoliquiritigenin in licorice functions as a hepatic protectant by induction of antioxidant genes through extracellular signal-regulated kinase-mediated NF-E2-related factor-2 signaling pathway. 2016 Eur J Nutr pmid:26593436
Kwon SS et al. Physicochemical properties of pH-sensitive hydrogels based on hydroxyethyl cellulose-hyaluronic acid and for applications as transdermal delivery systems for skin lesions. 2015 Eur J Pharm Biopharm pmid:25753198
Zhang XY et al. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. 2013 Eur J Pharm Sci pmid:23624327
Welle R et al. Induced plant responses to pathogen attack. Analysis and heterologous expression of the key enzyme in the biosynthesis of phytoalexins in soybean (Glycine max L. Merr. cv. Harosoy 63). 1991 Eur. J. Biochem. pmid:1840523
Wegener JW and Nawrath H Cardiac effects of isoliquiritigenin. 1997 Eur. J. Pharmacol. pmid:9178653
Wegener JW and Nawrath H Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle. 1997 Eur. J. Pharmacol. pmid:9105881
Tawata M et al. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. 1992 Eur. J. Pharmacol. pmid:1555643
Kim JY et al. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. 2008 Eur. J. Pharmacol. pmid:18295200
Liu B et al. Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: role of cGMP/PKG pathway. 2008 Eur. J. Pharmacol. pmid:18462716
Zhang B et al. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis. 2018 Eur. J. Pharmacol. pmid:29277717
Jang EY et al. Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABA(B) receptor. 2008 Eur. J. Pharmacol. pmid:18495107
Chi JH et al. Isoliquiritigenin inhibits TNF-α-induced release of high-mobility group box 1 through activation of HDAC in human intestinal epithelial HT-29 cells. 2017 Eur. J. Pharmacol. pmid:28012970
Kanazawa M et al. Isoliquiritigenin inhibits the growth of prostate cancer. 2003 Eur. Urol. pmid:12706007